Thyroid Cancer Drugs Market Insights on BRAF and RET Inhibitor...

agregó una foto Other

2026-05-18 11:46:20 - Translate -

Thyroid Cancer Drugs Market Insights on BRAF and RET Inhibitor Developments

The global thyroid cancer drugs market was valued at USD 1.58 billion in 2024 and is projected to grow from USD 1.81 billion in 2025 to USD 5.37 billion by 2033, expanding at a CAGR of 14.6% during the forecast period (2025–2033). The increasing prevalence of thyroid cancer worldwide, coupled with rising investments in oncology research and advancements in precision medicine, is...

0 Commentarios 0 Acciones 68 Views 0 Vista previa